Erythropoietin / Epoetin – Anaemia in renal failure pre-dialysis.

Drug Name (Brand)	Erythropoietin / Epoetin *(Eprex®, NeoRecormon® and others)*
Indication	Anaemia in renal failure pre-dialysis.
Traffic Light Classification	Double Red
NICE TA (plus link)	Chronic kidney disease: managing anaemia \| Guidance \| NICE
Further Information: NICE recommendations, summary of meeting discussions, links to additional supporting docs etc. April 2005: Use in pre-dialysis patients is not commissioned in Norfolk & Waveney. May 2011: The TAG noted NICE Clinical Guideline 114 (February 2011) – Anaemia management in people with chronic kidney disease (www.nice.org.uk/CG114) The advice in the NICE clinical guideline covers: Detecting and diagnosing anaemia of chronic kidney disease managing anaemia of chronic kidney disease, and other health problems or treatments that may affect it. It does not specifically look at anaemia in people with chronic kidney disease, where the anaemia may be caused by other problems. April 2013: NHS England SCG took over commissioning responsibility for this treatment. July 2015: The TAG and the D&TCG noted and acknowledged (NICE) NG 8 (June 2015) – Anaemia management in people with chronic kidney disease.
Date of TAG recommendation / ratification		4/1/2005	Review Date